Correlation of Human Papillomavirus types with the level of damage in women attended in a private laboratory
DOI:
https://doi.org/10.34119/bjhrv6n2-160Keywords:
Cancer, HPV, cervical intraepithelial neoplasia, sexually transmitted infection, women, health, cytologyAbstract
Introduction: the Human Papillomavirus (HPV) is a virus capable of promoting various types of skin and mucosal lesions, which can be malignant or benign. Some of them can cause genital warts, and others can reach the cervix and cause a Cervical Intraepithelial Neoplasm (CIN) that can progress to a more advanced stage, which is cancer. The sexually active population is more likely to come into contact with the virus at some point in life, and as a result, the human papillomavirus is the most common sexually transmitted infection (STI) in the world. Objective: to evaluate the incidence of HPV in women attended at a private laboratory in Fortaleza/CE. Method: this was a quantitative, cross-sectional, retrospective and descriptive research, using data from the patients' medical records. Results: after analyzing the patient’s medical records, it was observed that the predominant age group in this study was concentrated between 16 and 34 years old. Furthermore, it was evident that the vast majority of women obtained positive results for HPV, and they arrived with observations in the search for screening. Furthermore, the most prevalent intraepithelial lesions were LSIL and ASC-US. Conclusion: HPV was more associated with young women, and screening is of paramount importance since HPV is asymptomatic, and this factor can lead to women's erroneous thinking that without evident symptoms there is no lesion.
References
Duarte DV, Vieira RC, Brito EB, Pinheiro MDCN, Monteiro JDSV, Valente MDR, et al. Prevalence of Human Papillomavirus Infection and Cervical Cancer Screening among Riverside Women of the Brazilian Amazon. Rev Bras Ginecol Obstet. 2017 Jul;39(7):350-357. English. doi: 10.1055/s-0037-1604027. Epub 2017 Jun 28. PMID: 28658700.
Colpani V, Soares-Falcetta F, Bacelo-Bidinotto A, Kops NL, Falavigna M, Serpa Hammes L,et al. Prevalence of human papillomavirus (HPV) in Brazil: A systematic review and meta-analysis. PLoS One. 2020 Feb 21;15(2):e0229154. doi: 10.1371/journal.pone.0229154. PMID: 32084177; PMCID: PMC7034815.
Ayres ARG, Silva GAE, Teixeira MTB, Duque KCD, Machado MLSM, Gamarra CJ, et al. HPV in women assisted by the Family Health Strategy. Rev Saude Publica. 2017 Oct 5;51:92. doi: 10.11606/S1518-8787.2017051000065. PMID: 29020120; PMCID: PMC5676731.
Libera LSD. Alves GNS, Souza HG, Carvalho MAS. Avaliação da infecção pelo Papiloma Vírus Humano (HPV) em exames citopatológicos. Brazilian Journal of Clinical Analysis, v. 48, n. 2, p. 138-43, 2016.
Melo WA. Peloso, SM, Alvarenga A, Carvalho MDB. Factors associated with abnormalities of the cytopathological uterine cervix test in South of Brazil. Revista Brasileira de Saúde Materno Infantil [online]. 2017, v. 17, n. 4 [Accessed 27 July 2021] , pp. 637-643. Available from: <https://doi.org/10.1590/1806-93042017000400002>. ISSN 1806-9304. https://doi.org/10.1590/1806-93042017000400002.
Silva RJC, Sudenga SL, Sichero L, Baggio ML, Galan L, Cintra R, et al. HPV-related external genital lesions among men residing in Brazil. Braz J Infect Dis. 2017 Jul-Aug;21(4):376-385. doi: 10.1016/j.bjid.2017.03.004. Epub 2017 Apr 8. PMID: 28399426; PMCID: PMC6561086.
Van Doorslaer K, Chen Z, Bernard HU, Chan PKS, DeSalle R, Dillner J, et al. ICTV Virus Taxonomy Profile: Papillomaviridae. J Gen Virol. 2018 Aug;99(8):989-990. doi: 10.1099/jgv.0.001105. Epub 2018 Jun 21. PMID: 29927370; PMCID: PMC6171710.
Teixeira LO, Amaral SC, Finger-Jardim F, da Hora VP, Gonçalves CV, Soares MA, et al. Frequência do Papilomavírus Humano na placenta, no colostro e no sangue do cordão umbilical [Frequency of Human Papillomavirus in the placenta, in the colostrum and in the umbilical cord blood]. Rev Bras Ginecol Obstet. 2015 May;37(5):203-7. Portuguese. doi: 10.1590/SO100-720320150005293. PMID: 26107570.
Eleutério RMN, Oliveira MAP, Jacyntho CMA, Rodrigues JF, Cavalcante DIM, Eleutério Junior J. Prevalence of HPV in Adolescents Virgins and Sexually Active at a University Hospital in the City of Rio de Janeiro, Brazil. ISRN Infectious Diseases , v. 2013, p. 1-5, 2013. https://doi.org/10.5402/2013/387961
Salazar LJ, Benavides MR, Boogaard S, Marín Y. Estrategias latinoamericanas para la vacunación contra el virus del papiloma humano - una revisión temática. Hacia promoc. salud. vol. 22, núm. 2, pp. 129-143, 2017.
Orlando G, Frati ER, Fasolo MM, Bianchi S, Matteelli A, Mazza F, et al. Incident genital HPV infections and potential impact of HPV vaccines in adult women living with HIV/AIDS. Hum Vaccin Immunother. 2019;15(7-8):1904-1910. doi: 10.1080/21645515.2018.1528834. Epub 2018 Oct 12. PMID: 30261149; PMCID: PMC6746504.
Silva ER, Macêdo FLS, Soares LRC, Rosal VMS, Carvalho NAL, Rocha MGL. Diagnóstico molecular do papilomavírus humano por captura híbrida e reação em cadeia da polimerase. Femina; 43(4): 181-184, jul.-ago. 2015.
Rodrigues AF, Sousa JA. Papilomavírus humano: prevenção e diagnóstico. Revista de Epidemiologia e Controle de Infecção [Internet]. 2015;5(4):197-202.
BRASIL. Ministério da Saúde. Conselho Nacional de Saúde. Resolução n. 466, de 12 de dezembro de 2012. Aprova diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Brasília, Diário Oficial da União, 12 dez. 2012.
Lie AK, Tropé A, Skare GB, Bjørge T, Jonassen CM, Brusegard K, et al. HPV genotype profile in a Norwegian cohort with ASC-US and LSIL cytology with three year cumulative risk of high grade cervical neoplasia. Gynecol Oncol. 2018 Jan;148(1):111-117. doi: 10.1016/j.ygyno.2017.10.031. Epub 2017 Nov 11. PMID: 29132873.
Tifaoui N, Maudelonde T, Combecal J, Vallo R, Doutre S, Didelot MN, et al. High-risk HPV detection and associated cervical lesions in a population of French menopausal women. J Clin Virol. 2018 Nov;108:12-18. doi: 10.1016/j.jcv.2018.08.010. Epub 2018 Aug 31. PMID: 30196012.
Ejegod DM, Junge J, Franzmann M, Kirschner B, Bottari F, Sideri M, et al. Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples. Papillomavirus Res. 2016 Dec;2:31-37. doi: 10.1016/j.pvr.2016.01.003. Epub 2016 Mar 2. PMID: 29074183; PMCID: PMC5886872.
Martins TR, Mendes de Oliveira C, Rosa LR, Campos-Centrone C, Rodrigues CL, Villa LL, et al. HPV genotype distribution in Brazilian women with and without cervical lesions: correlation to cytological data. Virol J. 2016 Aug 12;13:138. doi: 10.1186/s12985-016-0594-3. PMID: 27515763; PMCID: PMC4982268.
Porcari AM, Negrão F, Tripodi GL, Pitta DR, Campos EA, Montis DM, et al. Molecular Signatures of High-Grade Cervical Lesions. Front Oncol. 2018 Apr 12;8:99. doi: 10.3389/fonc.2018.00099. PMID: 29707519; PMCID: PMC5907284.
Veijalainen O, Tuomisaari S, Luukkaala T, Mäenpää J. High risk HPV testing in the triage of repeat ASC-US and LSIL. Acta Obstet Gynecol Scand. 2015 Sep;94(9):931-6. doi: 10.1111/aogs.12686. Epub 2015 Jun 24. PMID: 26053676.
Okuyama NCM, Cezar-Dos-Santos F, Pereira ÉR, Trugilo KP, Cebinelli GCM, Sena MM, et al. Genetic variant in CXCL12 gene raises susceptibility to HPV infection and squamous intraepithelial lesions development: a case-control study. J Biomed Sci. 2018 Sep 18;25(1):69. doi: 10.1186/s12929-018-0472-y. PMID: 30227860; PMCID: PMC6145110.
